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Abstract 
 
Nanomaterials, classified as materials within the 1 - 100 nanometer range, have 
seemingly endless applications that can be beneficial to both the military as well as to the 
greater society.  Even with increased funding in recent years there is still a vast need for 
characterization data from these materials in order to quantify risks to both humans as 
well the environment.  Nanomaterials are of great interest to the Air Force and the 
military because of their many applications in munitions, sensing, electronics, and life 
sciences including pharmaceutical drug delivery and medicine.  Copper nanoparticles 
(Cu-NPs) have already been considered for a range of uses based on their antimicrobial 
properties and they are widely used in lubricants, inks and other applications that make 
use of their anti-microbial properties.  However, the biological effects of Cu-NPs can 
vary based on their physicochemical properties; in particular, their oxide content and 
primary size.  Cu-NPs can be oxidized and exist as copper oxide nanoparticles (CuO-
NPs).  Also, larger size Cu-NPs can exist as micron-sized copper particles (Cu-MSP).  It 
is very important to the Air Force and especially the Bioenvironmental Engineering 
career field to increase the understanding of Cu-NPs and the possible health impacts from 
nanomaterial exposure prior to wide-spread industry and military use, particularly in 
occupational settings.  Therefore, the purpose of this research is to thoroughly 
characterize the properties of three different copper samples upon suspension into 
aqueous solutions over time:  Cu-NPs (Cu 25 nm), CuO-NPs (CuO 40 nm), and Cu-MSP 
(Cu 500nm).  Additionally, this research seeks to observe in vitro effects upon murine 
neuroblastoma cells (N2A) by these three types of particles as well as by CuCl2.  
Microscopy techniques indicate observable changes in oxidation for Cu-NP 25 nm and 
 v 
CuO-NP 40 nm after suspension in water over long incubation.  In general, 
agglomerations of the particles increase when dosed with the endocytosis inhibitor 
Dynasore.  In terms of cellular viability, CuCl2 is the least toxic at all concentrations.  
Cu-NP 25 nm is less toxic at low concentrations (< 25 µg/mL) than Cu-MSP 500 nm and 
CuO-NP 40 nm.  At concentrations above 25 µg/mL, Cu-NP 25 nm becomes comparable 
in toxicity to CuO-NP 40 nm and more toxic than Cu-MSP 500 nm.    
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CHARACTERIZATION AND IN VITRO TOXICITY OF COPPER NANOPARTICLES 
(Cu-NPs) IN MURINE NEUROBLASTOMA (N2A) CELLS 
 
 
 
I. Introduction 
 1.1   Background 
Nanotechnology by definition means the creation and manipulation of materials at 
the nanoscale level (1-100 nm) and is currently “experiencing massive, world-wide 
investment as well as a tremendous rise in consumer products” (Schrand & Hussain, 
2010).  Nanotechnology is an important area of research for many reasons, including its 
potential to transform many industries at phenomenal speeds.  Research in 
nanotechnologies continues to expand worldwide everyday and the National Science 
Foundation (NSF) estimates that nanotechnology will have a significant impact on the 
global economy.  Specifically, the National Institute for Occupational Safety and Health 
(NIOSH) reports that nanotechnology will have an impact of over 1 trillion dollars and 
employ over 2 million workers worldwide (NIOSH, 2009). 
Despite all the research and development funds pouring in, much is still unknown 
about potential hazards, safe handling practices, and effects on humans and the 
environment of nanomaterials.  There is also a growing concern for public safety as well 
as ecosystem health.  
 
1.2   Problem Identification 
 
  
 
Cu Nanoparticles (Cu-NPs), Cu micron-size particles (Cu-MSPs) and Cu Oxide 
Nanoparticles (CuO-NPs) are already in use as additives in inks, lubricants, and metallic 
coatings.  They are often emitted as particulates in smelters, metal foundries, and as torn 
particles from asphalt and rubber tires (Midander et al., 2009).  With additional 
applications in the future, there is still no clear understanding regarding their long-term 
biological consequences.  Only a few studies have attempted to thoroughly characterize 
Cu-NPs, Cu-MSPs and CuO-NPs and investigate the toxicological effects of direct 
exposure of cultured cells to these nano and micron-sized particles.  Additionally, 
different physicochemical properties of the particles are likely linked to their toxicity. 
Therefore, it is necessary to thoroughly characterize the particles prior to toxicity 
assessment.  Lastly, toxicity data are not typically extrapolated to account for different 
sized particles.  This needs to be accomplished, as particles agglomerate upon suspension 
in aqueous environments. 
 
1.3   Research Objectives 
The purpose of this investigation was to thoroughly characterize Cu-NPs, Cu-
MSPs and CuO-NPs upon their suspension in water and to determine the toxic effect of 
these copper nanoparticles on Murine Neuroblastoma (N2A) Cells.  Specifically, the 
following issues were addressed: 
 1. Characterization of copper nanomaterial’s physiochemical properties                                                              
(morphology, shapes, agglomeration, spectral signature). 
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 2.   Toxicity assessment of Cu-NPs, Cu-MSPs and CuO-NPs on the murine 
neuroblastoma (N2A) cell line.   
 
1.4   Research Focus 
The focus of this basic research was limited to characterization of copper 
nanoparticles and micron-sized particles and the in vitro exposure of murine 
neuroblastoma cells to these copper nanoparticles.  The goal was to gain a better 
understanding regarding the physicochemical properties of the copper nanoparticles prior 
to in vitro toxicity testing for future modeling and in vivo exposure studies and ultimately 
to develop recommended work place exposure limits. 
 
1.5 Methodology 
Prior to in vitro cell culture experiments, the effect of the cell culture media upon 
the copper nanoparticles was investigated.  Previous research has demonstrated that 
suspension of nanoparticles in cell culture media generally leads to the aggregation of 
most compositions of nanoparticles (Murdock et al., 2008). 
In vitro cell culture and aseptic techniques were used in this research.  Murine 
neuroblastoma (N2A) cells were cultured in T-75 plastic flasks and exposed to various 
concentrations of Cu-NPs (25 nm), CuO-NPs (40 nm) and Cu-MSPs (500 nm) over 
certain time periods.  The viability of the N2A cells after exposure to each type of Cu-
NPs, Cu-MSPs and CuO-NPs at various concentrations was determined by measuring the 
mitochondrial function of the cell.  Mitochondrial function acts as an indicator of 
metabolic activity and therefore also elucidates cell viability.  The 3-(4,5-
 
  
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay was used for the assessment of cellular viability based on mitochondrial 
function.   
Morphological characteristics of the cells after exposure to each type of Cu 
particle, were observed with three different imaging techniques – two forms of Scanning 
Electron Microscopy (SEM); high resolution and environmental, and two forms of 
Transmission Electron Microscopy (TEM); high resolution and low voltage.  
Agglomeration characteristics were observed by using Dynamic Light Scattering (DLS) 
in dosing media along with the endocytosis inhibitor Dynasore.   
 
1.6   Assumptions/Limitations 
(1) The properties of Cu and CuO NPs and Cu micron particles were expected to 
change after dry powder particles were suspended in water, dosing and 
growth medias. 
(2) Cells dosed at the same Cu particle concentration were equally exposed 
throughout the experiment and that the exposure method used was 
satisfactorily conducted.  
(3) Studying the toxicity of copper particles using neuroblastoma cells as a model 
has relevance to toxicity of the particles to humans. 
(4) In Vitro results are limited and cannot be directly extrapolated without caution 
to predict in vivo results.   
 
1.7   Implications 
 
 5 
        Nanoparticles are used more and more widely in both consumer products and the 
workplace.  While researchers continue to study nanoparticles, a knowledge gap still 
exists.  We need to ramp up efforts to determine health exposure risks as well as potential 
environmental effects.  This research was conducted in order to elucidate copper nano- 
and micron-sized particles’ properties to aid in the evaluation of acceptable exposure 
limitations in the occupational setting.  Further investigations and measurements may 
help define control requirements and regulations for these and other nanoparticles.  With 
the improved understanding and characterization of these particles we will be able to 
better define negative health and environmental effects prior to wide-scale use, thereby 
creating a healthier workplace environment for workers and consumers of nano- and 
nanobiotechnology.   
 
1.8 Overview of Document 
       This document contains five chapters.   
Chapter Two: A review of selected literature on current and future uses of nanoparticles 
including consideration for health and safety as well as an overview of copper toxicity.  
The literature demonstrates that the toxicity of Cu-NPs, Cu-MSPs and CuO-NPs can be 
characterized according to morphology, possibly size, cell viability assays, and studies 
comparing the toxicity of Cu particles to that of other particles.     
Chapter Three: Provides a concise explanation of the methods used to obtain data.   
Chapter Four:  Presents an analysis and possible interpretation of the data obtained. 
Chapter Five:  Draws final conclusions and suggests future research. 
 
 
  
II. Literature Review 
2.1 Background 
This literature review presents an overview on the basic background of 
nanoparticles, the current societal uses of nanoparticles and relevant health and safety 
considerations for the particles.  A general summary of copper toxicity is provided as 
well as relevant disease associations and environmental fate of these particles.  The 
literature review indicates that general conclusions can be drawn from cellular toxicity 
experiments with copper and shows that toxicity can be somewhat characterized 
according to cell viability, morphology, and size.   
 
2.2 Nanoparticles (NPs) 
Defined as particles with a diameter of less than 100 nm, nanoparticles are “a 
heterogeneous group of materials that differ in many characteristics and physiochemical 
properties, such as particle size, surface area, shape, morphology, elemental composition, 
solubility, and agglomeration state” (Midander et al., 2009).  Thus, in order to assess the 
in vitro and in vivo toxicity of nanoparticles, a number of different characterization 
methods are required.    
The following illustration (Fig 2-1) provides examples of nanoarchitectures as 
well as research that has led to the manipulation of nanomaterials.  The comparison 
between naturally occurring bio-structures and bio-molecules to manufactured 
nanostructures demonstrates the progress made in developing manmade structures that 
are comparable in size to the smallest natural materials. 
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Fig 1. Comparison of things found in nature to nanostructures/nanomaterials 
The above "Scale of Things" chart was designed by the Office of Basic Energy Sciences 
(BES) for the U.S. Department of Energy 
(http://www.science.doe.gov/bes/scale_of_things.html) 
 
The unique properties of nanoparticles are in large part a function of particle size.  
Smaller particles have a much larger surface area-to-volume ratio as well as number of 
particles in the same volume as compared to larger particles.  Interestingly, this size 
difference equates to enhanced inflammatory response and increased toxicity for many 
nanoparticles when compared to larger particles of the same chemical composition 
(Oberdörster et al., 2005a).   
 
  
From a toxicity perspective, the solubility of particles plays a two-fold role.  
While more soluble particles, such as dissolved metal in ionic form, may contribute to 
increased toxicity, more stable but less soluble forms of the metal may persist longer in 
bio-systems and thus bio-accumulate  in both the organism and the environment 
((Midander et al., 2009). 
It is important to keep in mind that NPs are a heterogeneous group of materials 
that can vary widely due to size, morphology, shape, surface area, elemental composition, 
and solubility as well as agglomeration rate and sizes (Schrand and Hussain, 2010).  
There are many different types of nanoparticles that can be  categorized based upon their 
composition into the following groups: 1) organic nanoparticles (e.g. polymers and 
dendrimers), 2) inorganic nanoparticles (e.g. metallic nanoparticles), 3) organic/inorganic 
hybrids (e.g. nanocomposites), 4) carbon based (e.g. functionalized fullerenes), 5) 
liposomes (e.g. functionalized, inclusion complexes), and 6) biological nanoparticles (e.g. 
protein and peptide- based nanoparticles with other biological components).  Although 
almost all of these types of NPs have potential beneficial applications for  the military, 
industry, and health sectors, there is still much unknown about potential hazards, safe 
handling practices, and effects on humans and the environment.  Adverse health concerns 
include “cardiovascular and pulmonary diseases and an increased risk of developing lung 
cancer” (Midander et al., 2009). 
 
2.2.1 Current and Future Uses 
 It is not possible to cover all the various applications of nanotechnology.  In order 
to gain an understanding and appreciation for this area of research, a few specific 
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examples are highlighted here, including projected future uses.  Table 1 shows an 
overview of some of the applications in nanotechnology (Schrand et al., 2010). 
 
Table 1. Overview of Nanoparticle Types and Biotechnology Applications 
 
 
 
 Nanotechnology may be the answer to our growing energy needs via the use of 
high-efficiency organic photovoltaics (OPVs).  Nanostructered thin films, “composed of 
layers of semi-conducting organic materials (polymer or oligomers)” absorb photons 
from the solar spectrum and make up the OPVs (Dingman, 2005).  Because OPVs 
composed of nanomaterials can be manufactured by a solution-based method they can be 
made much more cheaply than “inorganic” counterparts.  Still, challenges exist before 
these devices can be mass produced, with the main concern being low solar energy 
Nanoparticle Abbreviation Application
Aluminum Al Fuel additive/propellant, explosive, wear resistant coating additive
Gold Au Cellular Imaging, Photodynamic Therapy
Iron (oxide) Fe, Fe3O4, Fe2O3 Magnetic imaging, environmental remediation
Silica SiO2
Fabrication of electric and thermal insulators, catalyst supports, drug carriers, 
gene delivery, adsorbents, molecular sieves, and filler materials
Silver Ag Anti-microbial, Photography, Batteries, Electrical
Copper Cu
Antimicrobial (ie. antiviral, antibacterial, antifouling, antifungal), antibiotic 
treatment alternatives, nanocomposite coating, catalyst, lubricants, inks, filler 
materials  for enhanced conductivity and wear resistance 
Cerium (oxide) CeO2
 Polishing and computer chip manufacturing , fuel additive to decrease 
emissions
Manganese (oxide) Mn Catalysis, Batteries
Nickel (oxide) Ni Conduction, magnetic properties, catalysis, battery manufacture, printing inks
Titanium Dioxide TiO2
Photocatalyst, Antibacterial coating, sterilization, Paint, Cosmetics, 
Sunscreens
Zinc (oxide) Zn, ZnO Skin Protectant, Sunscreen 
 
  
conversion efficiencies.  Another area of energy research is in the area of fuel cells, 
because they are potentially more energy efficient than conventionally generated power.  
Researchers have started to use nanomaterials in the catalyst layer of fuel cells as they 
provide much larger active surface area due to their high surface areas.  This increase in 
active surface area equates to an increase in the catalytic rate of oxidation or reduction 
while minimizing the amount of precious metals needed.  In addition, researchers found 
that “the electrocatalytic properties of the materials are sensitive to particle size, so 
increased catalytic activity can be observed for nanoparticles and nanomaterials” 
(Minteer, 2005).  However, one of the biggest benefits of using nanoparticles and 
nanomaterials is that the weight of precious metals is greatly reduced, and thus cost is 
also reduced.  The need for a large amount of precious metals, thereby driving up cost, 
has been the major limitation of fuel cells (Minteer, 2005).   
Nanopowders and nanoparticle dispersions make very uniform coatings because 
of their small and often homogenous size.  Indium tin oxide and antimony tin oxide are 
well known coatings that provide optical transparency and electrical conductivity to 
materials.  Examples of commercial uses include interactive touch screens and antistatic 
coatings utilizing the conductivity of the nanoparticles to dissipate the static charge.  
Nanoscale aluminum oxide and titanium oxide are also optically transparent and can 
greatly decrease abrasion when compared to traditional coatings.  Other coatings of 
interest include zinc oxide and other rare-earth oxides that are also UV-reflective, but 
optically transparent, thus providing protection of surfaces from degradation due to UV 
exposures (Grocholl, 2005a).   
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 Researchers have also been able to develop biosensors with near-infrared optical 
capability.  For example, single-walled carbon nanotubes (SWNT) are able to “modulate 
their fluorescence emission in response to specific biomolecules” (Strano et al., 2005).  A 
SWNT coupled enzyme bio-conjugate was used to detect glucose concentration by 
capitalizing on the fact that carbon nanotubes fluoresce in the near-infrared region and 
that human tissues and biological fluids are transparent to their emission.  The sensor can 
then be employed to be excited by a near-infrared source from within the tissue and 
provide continuous blood glucose levels by producing the appropriate fluorescence 
response.  The great potential benefit of this research is that the principle can be applied 
to many other chemical systems in order to develop new types of sensors for use in both 
medicine and biology (Strano et al., 2005). 
 SWNT have also been investigated for use in polymer composites.  The main 
issue with composites containing nanotubes is the poor solubility of SWNTs in polymers, 
which can result in segregation.  Therefore, successful SWNT composites require strong 
adhesion between the polymer matrix and SWNT as well as uniform dispersion within 
the matrix.  In order to improve dispersion, coatings from surfactants and polymers are 
used to achieve “a) tighter bonding with the grapheme surfaces, b) miscibility with 
polymer matrixes of composites and c) substantially smaller concentration necessary for 
the preparation of SWNT dispersions” (Kotov, 2005).   
 Novel nanotechnology methods use layer-by-layer (LBL) nanoassembly 
composed of alternating oppositely charged polyelectrolytes, nanoparticles and proteins 
to create ultrathin multi-layer nano-capsules for targeted drug delivery.  Examples of 
nanoparticles used successfully include different diameter and surface-charged gold, 
 
  
silica, nanoclay-montmorillonite, alumina and titanium dioxide.  Nanoarchitects need a 
wide variety of nanoparticles with varying properties and dimensions to proceed with this 
type of research.  Ideally, good candidate nanoparticles are “monodispersed, stable in 
solution, charged nanoparticles of noble metals, metal oxides and ceramics with 
diameters of 5, 10, 20, 50 and 100 nm” (Lvov, 2005).   
  Continuous carbon or boron fiber-reinforced aluminum and magnesium, as well 
as silicon carbide reinforced aluminum belong in the category of metal matrix composites 
(MMCs).  These MMCs have already been used in aerospace applications mainly due to 
their light weight and their ability to be tailored to possess specific properties.  Metal 
matrix nanocomposities have improved physical and mechanical properties when 
compared to their micron-size counterparts.  In addition, carbon nanotubes have “much 
higher strength, stiffness, and electrical conductivity as compared to metals, and therefore 
can significantly increase these properties of MMCs” (Rohatgi et al., 2005).   
Another area of interest is reducing the cost of producing these materials.  Most of 
the research in synthesizing nanocomposites has involved the use of powder metallurgy 
techniques.  This method is not only expensive, but also easily contaminated.  Other 
methods of interest include stir mixing, squeeze casting and pressure infiltration that can 
be both rapid and inexpensive in producing large quantities of components that are of 
target sizes.  Although there are still challenges in mixing nanoscale particles in metallic 
melts mainly due to agglomeration, several research teams have shown that there are 
dispersion techniques available (Rohatgi et al., 2005).   
It is easy to recognize the importance of nanotechnology and nanomaterial 
research just by the sheer amount of money being allocated to these fields.  Lux Research 
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and the President’s Council of Advisors on Science and Technology (PCAST) have 
shown that “the United States (US) is a global leader among governments funding 
nanotechnology” (A Matter of Size: Triennial Review of the National Initiative, 2006).  It 
is important to keep in mind that it is complicated to compare nations’ spending on 
nanotechnology due to differences in calculating and budgeting expenditures.  Various 
nations have different benchmarks in reporting what is public and private funding, how 
researchers’ salaries are defined, etc.  As seen in Fig 2-2, the United States leads in 
nanotechnology research spending, although that position is being challenged.  However, 
according to Cientifica’s 2003 Nanotechnology Opportunity Report, Japan’s launch of 
the Nano-Business Creation Initiative for creating new nanotechnology businesses in 
Japan and building their foundation as nanotechnology leaders of the future indicate that 
they also aspire to be a global leader in nanotechnology (A Matter of Size: Triennial 
Review of the National Initiative, 2006). 
 
 
 
 
  
 
Fig 2. World nanotechnology funding, 2005. (Left) Nanotechnology funding globally by 
source, 2005 (U.S. $ billion). (Right) Government nanotechnology funding by country, 
2005 (U.S. $ million). SOURCE: Lux Research, Inc. 2006. The Nanotech Report. 4th 
Edition. New York: Lux Research, Inc. 
 
 A more recent look at nanotechnology spending shows that more than 60 
countries now have their own nanotechnology programs.  These nations are most likely 
following the lead of the United States, who announced establishment of the US National 
Nanotechnology Initiative (NNI) in 2000.  In 2010, nine years after the initiation of the 
NNI, US federal spending dollars on nanotechnology has jumped from $464 million in 
2001 to $1.8 billion (Shapira & Wang, 2010).   
 More spending in turn leads to more research publications.  In fact, Shapira & 
Wang (2010) identified more than 91,500 nanotechnology articles published between 
August 2008 and July 2009 worldwide.  However, even though the publications featured 
researchers from 152 countries, 90% of the papers were written by authors from only 15 
countries.  The top four countries by author contribution are the United States (23%), 
China (22%), Germany (8%), and Japan (8%) (Shapira & Wang, 2010).   
 As seen in Fig 2-3, while the US remains the focal point on the nanotechnology 
map, US researchers partner with Chinese colleagues most often; although a strong 
cluster of collaboration efforts are also seen with some European countries.  However, 
even after ten years since the launch of the NNI, only a small number of countries still 
sponsor much of the world’s nanotechnology research; nanotechnology research has yet 
to become a global activity.  With competing technologies and limited funding, future 
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nanotechnology research will most likely not keep pace with the explosive growth of the 
past decade.  Shapira and Wang (2010) recommend more high-quality international 
collaborations for interested stakeholders to increase alliances with colleagues in other 
countries.   
 
Fig 3. A graphical depiction of nanotechnology research papers funded, with the node 
size being proportional to the total number of papers (Shapira & Wang, 2010). 
  
2.2.2 Uses of Copper Nanoparticles 
In our recent medical history, fungal infections have become a major health 
concern especially in immune-compromised patients such as those with acquired immune 
deficiency and patients undergoing chemotherapy treatment.  Concurrently, copper 
nanoparticles have been investigated for use in biotechnological applications that may 
 
  
one day combat some of these disease conditions.  For example, researchers have 
combined copper nanoparticles with a polymer material to make a composite capable of 
releasing metal species in a controlled manner in order to inhibit the growth of fungi and 
other pathogenic microorganisms (Cioffi et al., 2005).   
 The germicidal properties of copper have been well recognized, in both its 
particulate and soluble forms.  Copper and copper oxide dispersions have been used in 
maritime industries since the 19th century in antifouling coatings.  The downside to this 
application is the eventual mass release of copper compounds into the maritime system.  
However, more recently, Cioffi et al. (2005) proposed a similar strategy as a way to 
control the growth of saccharomyces cerevisiae yeast and molds through the use of 
nanocomposites with spinning coatings that are equipped to release copper.  They 
conclude that this nanostructured coating seem to be very promising as there is the 
capability to control the metal release (Cioffi et al., 2005).  Another area of interest is the 
incorporation of low-copper-loading materials into packaging materials for food.  
Furthermore, copper oxide nanopowder has also been suggested as an anti-microbial 
preservative for use in wood and food products (Grocholl, 2005b).   
 In addition to controlling the growth of yeasts and molds, Cu-NPs have also been 
shown to be effective in controlling the growth of bacteria such as Escherichia coli and 
Bacillius subtilis.  The theorized mechanism of Cu-NPs acting as an antibacterial agent is 
“due to the interactions with the SH groups leading to protein denaturation” (Schrand et 
al., 2010).   
 Manufactured nanosized copper particles have also been used as additives in 
lubricants, inks, polymers and plastics, as well as metallic coatings.  They provide 
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excellent lubrication in oil due to mending effects and as an additive they reduce friction 
as well as wear and tear on surfaces (Liu et al., 2004).  In lithium ion batteries, nanosized 
copper particles are deposited evenly onto graphite surfaces as an anode material (Guo et 
al., 2002).  Copper has also been used in various skin products to enhance healing and 
prevent infection (Midander et al., 2009).   
 
2.3 Health and Safety Considerations for NPs 
As mentioned earlier, the National Nanotechnology Initiative (NNI) is a federal 
interagency committee that was established in 2000 with aims to “expedite the discovery, 
development, and deployment of nanotechnology in order to achieve responsible and 
sustainable economic benefits, enhance the quality of life, and promote national security” 
(A Matter of Size: Triennial Review of the National Initiative, 2006).  The NNI has 
outlined goals to ensure responsible development of nanotechnologies and the conduct of 
responsible research.  Some of NNI goals include carrying out research in order to 
“characterize environmental, health, and safety (EHS) impacts of the development of 
nanotechnology and assessment of associated risks”, educational efforts directed at 
undergraduate programs and public outreach, and research aimed to identify and quantify 
nanotechnology implications in a broader societal, economical, ethical, legal and 
occupational contexts (A Matter of Size: Triennial Review of the National Initiative, 
2006). 
 However, thus far, the committee has found that the Environmental, Health, and 
Safety (EHS) effects data thus far produced by nanotechnology research are inconclusive.  
The NNI state that risk assessments are poorly defined and need to be further developed.  
 
  
In addition, more research must be conducted to assess for EHS hazard potentials from 
various nanomaterials.  Ambiguous results were also obtained on the health and well-
being of laboratory animals.  Lack of in vitro and in vivo studies are partially to blame for 
the deficiency in thorough characterization of nanomaterials.  Achieving the goal of 
obtaining valid and reproducible EHS data will depend on further research to produce 
more specific risk-based guidelines.  Until this goal can be met, the committee suggests 
precautionary measures in order to protect all nanomaterial workers, the public, and the 
environment.  Addressing the social and ethical challenges of nanotechnology will 
involve the collaboration of scientists, engineers, toxicologists, and policymakers.  
Throughout this national effort, it is important for the public to remain engaged in order 
for risks to be adequately addressed and communicated and to ensure that 
nanotechnology research is carried out in a responsible manner (A Matter of Size: 
Triennial Review of the National Initiative, 2006). 
As applications in nanotechnology continue to expand and consumers find more 
and more nanoparticles in everyday products the area of health concerns will also gain 
considerable attention.  Thus far, most of the studies related to nanoparticles have been 
focused on respiratory exposures.  Other exposure routes including dermal and ingestion 
have also started to be considered as potential routes of concern.  A likely scenario for 
ingestion to occur as a secondary route of exposure may involve mucociliary escalator 
action where nanoparticles originally cleared by the respiratory tract are then ingested.  In 
addition, “nanomaterials can be ingested directly via water, food, cosmetics, drugs, drug 
delivery devices, etc (Chen et al., 2006).  Studies have also indicated that differing sized 
nanoparticles may induce various toxicological effects after gastrointestinal intake.   
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2.3.1 Physicochemical Characteristics vs. Biological Activity 
High surface area to volume ratio is a highly desirable aspect of nanoparticles, 
such as in catalytic reactions, but one which can also have grave effects in terms of 
toxicity.  An analogy can be drawn from the ratio of surface area to volume of molecules 
or atoms to that of the potential biological and chemical activity from nanoparticles.  
With decreasing particle size, this ratio increases by orders of magnitude as seen in Table 
2. 
Table 2. Particle number and particle surface area per 10 µg/m³ 
airborne particles (Oberdörster et al., 2005b). 
 
 
   
 
 
  
 As seen in Table 2, surface molecules are plotted as a function of particles’ 
diameters.  At less than 100 nm, surface molecules increase exponentially with a decrease 
in particle diameter.  This results in a massive increase in chemical and biological activity 
potential.  It is important to understand that this is a two-sided issue.  On the one hand, 
increased biological activity can be very beneficial for “antioxidant activity, carrier 
capacity for therapeutics, and penetration of cellular barriers” (Oberdörster et al., 2005b).  
However, toxicity and oxidative stress of cellular functions may also dramatically 
increase.   
 
2.3.2 Benefits vs. Occupational Exposure Risks 
While the benefits of nanoparticles are indeed promising, the many useful 
properties of nanoparticles (size, surface area, reactivity) also pose a number of risks.  
Currently, a rising number of workers are potentially exposed to nanomaterials in 
“research laboratories, start-up companies, production facilities, and in operations where 
nanomaterials are processed, used, disposed or recycled” (Howard, 2005).  Many 
challenges remain in the determination of potential negative health effects and 
occupational safety risks from working with intentionally produced and engineered 
materials and devices.   But the larger goal is to realize potential benefits of 
nanotechnology research while being meticulously careful in minimizing risks associated 
with these endeavors (Howard, 2005).                                                                                                                                                                                                                                                                                                                                                                                     
 
2.3.2 Regulations 
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In terms of regulation requirements set forth for nanomaterials the issue is 
somewhat unclear.  The EPA has mainly focused its efforts towards regulating 
nanomaterials through the Toxic Substances Control Act (TSCA) where most materials 
are considered as chemical substances.  The regulatory approach used by the EPA 
follows a four-pronged approach that includes the following: pre-manufacture 
notifications, a significant new use rule, an information gathering rule, and a test rule 
(TSCA, U.S. EPA, 2011). 
Prior to the manufacturing of new chemical substances, companies must provide 
specific information to the EPA as required by TSCA.  The EPA then takes action to 
ensure that human and environmental contamination risks are minimized.  The EPA 
provides assistance to manufacturers when determining whether their nanomaterials fall 
under the new chemical category.  Since 2005 the EPA has reviewed over 100 new 
notifications for nanomaterials, and this number is expected to continue to rise.  The 
agency has taken a number of actions including “limiting the uses of the nanoscale 
materials, requiring the use of personal protective equipment, such as impervious gloves 
and NIOSH approved respirators, limiting environmental releases, and requiring testing 
to generate health and environmental effects data” (TSCA, U.S. EPA, 2011). 
It is important to note that there are exceptions made for certain manufacturers of 
new nanomaterials under certain conditions where possible exposures are very tightly 
controlled and risks are minimized to include environmental releases.  Another proposed 
rule developed under TSCA section 8a requires submission of additional information 
from manufacturers such as production volume, methods used, exposures and any 
relevant release information and all available safety data.  Lastly, under TSCA section 4 
 
  
the EPA proposed a testing rule for certain nanomaterials already in use.  Any new 
information on nanomaterials not already being tested by other Federal agencies would 
enable the agency to further understand any novel toxicity data that link certain chemical 
and physical characteristics to in vitro and in vivo toxicity (TSCA, U.S. EPA, 2011).   
 
2.3.2 Future Concerns and Funding 
 The NIOSH Nanotechnology Research Center (NTRC) was established in 2004 
largely due to the anticipated increase in current as well as future nanotechnology 
research developments and to study potential worker exposures.  NIOSH scientists form 
the bulk of NTRC researchers engaged in developing future NIOSH guidelines in 
nanotechnology health research.  A far-reaching collaboration effort from the combined 
efforts of government agencies, academia and the private sector has aided the 
development of a NIOSH strategic plan in nanotechnology research and guidance 
(Howard, 2005). 
 The strategic plan’s goals are as follows: 
1. Determine if nanoparticles and nanomaterials pose risks for work-related 
injuries and illnesses. 
2. Conduct research to prevent work-related injuries and illnesses due to 
nanotechnology products. 
3. Promote healthy workplaces through interventions, recommendations, and 
capacity building. 
4. Enhance global workplace safety and health through national and international 
collaborations on nanotechnology research and guidance. 
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 The NIOSH Office of Extramural Programs (OEP) works with the research 
community and awards grants in occupational safety and health grants.  To date, OEP has 
committed roughly 5.3 million dollars to nanotechnology research.  NIOSH also joined 
with the Environmental Protection Agency as well as the National Science Foundation in 
2004 and committed $7 million in funding of grants in continued research (Howard, 
2005).  
 
2.3 Copper Toxicity 
As a naturally occurring metallic compound, copper may exist by itself or may be  
associated with other elements.  Copper particulates released into the air may be from 
both natural and anthropogenic sources.  Volcanic eruptions are the main natural source 
of windblown copper particulates in dust.  Copper smelters or other ore processing 
facilities are sources of copper particulates from manufacturing processes.  Many times 
copper particles are removed from the atmosphere by precipitation, but they can be easily 
re-suspended in the form of copper dust.  In the U.S., the mean ranges of copper in the 
ambient air can vary widely, from 5 to 200 ng/m³ (ATSDR, 2004).   
 Copper releases into the waterways usually occur via natural weathering of soil 
and rocks or from anthropogenic sources such as the effluent of industries or sewage 
treatment plants.  Copper concentrations in drinking water may vary depending on pH 
and hardness of the local water.  Copper values in soil vary from 5 to 70 mg/kg and the 
estimated daily value of ingestion intake of copper from food is 1.0-1.3 mg/kg for adults 
(0.014-0.019 mg/kg/day).  The Food and Nutrition Board of the Institute of Medicine 
recommend dietary allowance (RDA) of “340 micrograms (μg) of copper per day for 
 
  
children aged 1–3 years, 440 μg/day for children aged 4–8 years, 700 μg/day for children 
aged 9–13 years, 890 μg/day for children aged 14–18 years, and 900 μg/day for adults” 
(ATSDR, 2004).  
Copper is a necessary trace element in the body, and mechanisms have evolved 
for the use, transport, and excretion of copper from the body.  Copper is an essential 
nutrient because it is incorporated as one of many metalloenzymes necessary for proper 
hemoglobin formation, carbohydrate metabolism, collagen, elastin and hair keratin, 
antioxidant defense, etc,.  Normal copper absorption occurs from the stomach and small 
intestine.  Complexing molecules have been known to exist in blood, but researchers 
have only been able to discover cellular copper transporters in the last decade or so.  For 
those individuals lacking the proper copper exporter pump, diseases such as Menkes or 
Wilson’s diseases result (Nordberg et al, 2007).   
  
2.4.1 Environmental Contamination 
As manufactured nanomaterial use increases in many commercial products, 
concerns have been raised regarding environmental release and contamination.  Because 
of their highly reactive nature, nanoparticles differ in many physical and chemical 
characteristics from their metallic ion counterparts.  Ganesh et al. (2010) evaluate 
nanocopper removal and the related toxicity in municipal wastewaters.  They note that 
wastewater treatment plants are most likely the last barrier to any nanomaterial release 
into the environment.  It is important to note that because of aforementioned differences 
of nanoparticles from metal ions, they also behave differently in biosolids.  In fact, 
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wastewater effluents models have already detected nanomaterial presence (Ganesh et al., 
2010).  
 Ganesh et al. (2010) conducted two sets of experiments evaluating copper 
nanoparticle and copper ion removal, one with normal activated sludge microorganisms 
and one with activated sludge filtrates that did not contain biomass.  The objective was to 
observe the amount of copper removal without the aid of biosorption.  For the first 
experimental condition, approximately 30-70% of copper ions were removed.  Cu NPs 
were removed at a higher percentage of around 90%.  Interestingly the team observed 
that nearly 25-55% of copper ions and 75-80% of CuNPs were removed in the activated 
sludge filtrates without biomass.  This indicates that copper biosorption was not a 
significant mechanism of copper removal.   
This preliminary study gives only rudimentary understanding of the fate and 
transport of CuNPs during wastewater treatment; other impacts including long-term 
effects are unknown.  Further concerns include changes to the microbial community of 
the activated sludge that may result from prolonged exposure to CuNPs.  Other 
mechanisms may take place, further altering CuNPs and other nanomaterials at the point 
of environmental release and during sludge handling and ultimately disposal.  Lastly, it 
was found that all residual samples of copper violated the National Toxics Rule (NTR) 
criteria for wastewater discharge of 8.9 µg/L (Ganesh et al., 2010). 
   
2.4.2 Exposure and Human Disease 
Many studies have found a number of systemic effects including gastrointestinal,  
 
  
hepatic, as well as renal effects following acute, intermediate, and chronic exposures to 
copper and an extensive database exists on the toxicity of ingested copper in animals, 
including immunological and developmental effects.  However, several studies have 
attempted to investigate potential neurological and reproductive targets, without 
conclusively finding any effects (ATSDR, 2004).   
 The general population comes in contact with copper through ingestion of food 
and water, and dermal contact with air, water or soil that contains copper.  Although 
contact primarily occurs from intake, the amount of copper uptake is usually less than the 
average dietary requirements (RDAs) for copper.  Inhalation of copper is a concern for 
individuals living near copper smelters or other refineries.  Workers in these facilities 
may experience high occupational exposures to copper.  Another concern is young 
children ingesting soil with high levels of copper while living near these facilities.  The 
EPA has identified copper hazards at 906 of 1,647 hazardous sites on the EPA’s National 
Priorities List (EPA NPL) (ATSDR, 2004).    
 Ingestion of excess copper is a concern because copper is easily absorbed from 
the stomach and the small intestine.  There are, however, several mechanisms for dealing 
with copper overload.  Excess copper that is absorbed in the intestinal mucosal cells 
binds to the metal binding protein metallothionein.  When the mucosal cells slough off 
the copper is also excreted.  The remaining copper in the system is then transported to the 
liver, and then becomes a part of the bile that will ultimately be excreted in feces.  
Copper homeostasis can be fairly effective in the body.  However, excess copper can 
result in serious damage to the body including “liver and kidney damage, anemia, 
immunotoxicity, and developmental toxicity” (ATSDR, 2004).  Excess copper that 
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cannot be mediated by homeostatic processes of the body will even bind with several 
enzymes to interfere with the protective mechanisms of cells from free radical damage 
(ATSDR, 2004).   
 For drinking water, the EPA has determined that it should not contain more than 
1.3 mg of copper per liter of water (1.3 mg/L).  The Occupational Safety and Health 
Administration (OSHA) has set a limit of “0.1 milligrams/cubic meter (mg/m3) for 
copper fumes (vapor generated from heating copper) and 1.0 mg/m3 for copper dusts 
(fine metallic copper particles) and mists (aerosols of soluble copper) in workroom air to 
protect workers during an 8-hour work shift (40-hour workweek)” (ATSDR, 2004).   
 
2.4.2.2 Respiratory and Gastrointestinal Distress 
While copper can be irritating to the respiratory tract, the most commonly 
reported adverse health effect is gastrointestinal distress.  Workers routinely exposed to 
copper dust have reported increased coughing, sneezing, running nose, fibrosis and 
generally increased vascularity in the nasal cavity.  Nausea and abdominal pain have been 
reported after drinking fluids high in copper, stagnant water from a first-draw copper pipe 
(such as first thing in the morning without any flushing of the water), or beverages stored 
in a copper container (ATSDR, 2004).   
 
2.4.2.3  Nervous System Effects & Neurological Disorders 
Murthy et al. (1981) conducted a study by administering either manganese 
chloride (1 mg manganese/mL drinking water) or copper sulfate (250 mg copper/kg food) 
to growing rats for 30 days.  The rats are normally maintained on a 10% casein diet.  
 
  
Neurobehavioral performances remained the same for the rats exposed only to copper in 
their diets but the combined exposure to copper and manganese produced elevated levels 
of dopamine and norepinephrine and a depression of 5-hydroxytryptamine, a dopamine 
metabolite.    These changes suggest that copper may adversely affect the nervous system 
but the study was inconclusive and suggested that further research be conducted to 
investigate the neurotoxic potential of copper (Murthy et al., 1981).   
 
2.5 Neuroblastoma in Humans 
 The cells used in the cellular experiments were Murine Neuroblastoma (N2A) 
cells.  Neuroblastoma in humans, occurs mostly in infants and children and is a cancerous 
tumor that develops from nerve tissues.  Since nerves run throughout the body, this 
disease can also occur in many areas of the body.  Neuroblastoma tumors usually develop 
in tissues forming the sympathetic nervous system (PubMed Health, 2011). 
 For children less than 15 years of age, sympathetic nervous system tumors 
account for 7.8% of all tumors, with most of the cases being neuroblastomas.  
Neuroblastomas are also the most common cancer of infancy, with double the incidence 
rate of the next most common disease in the first year of life: leukemia (National Cancer 
Institute, 2011).  Most of the tumors originate in the adrenal gland in the abdomen, close 
to the spinal cord, or sometimes in the chest area.  Unfortunately, the disease can easily 
metastasize to other regions, including bones of the extremities, head, pelvis, and 
shoulders as well as bone marrow, liver, skin, and lymph nodes (PubMed Health, 2011). 
 Survival for children diagnosed at age 1 to 4 is 83% and 40% for those 5 years or 
older.  The cause of neuroblastoma is largely unknown.  Certain medications, maternal 
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use of alcohol and tobacco and paternal occupational hazards have associations, but these 
are not clear (National Cancer Institute, 2011).  The diseases occur slightly more in boys 
than girls.   
 
  
III. Methodology 
3.1 Introduction 
The goal of this research was to characterize three copper nano and micron-sized 
particles and observe the particles’ relevant toxicity effects on N2A cells.  The 
characterization was carried out using a series of methods and equipment.  Malvern’s 
Zetasizer was used for Dynamic Light Scattering (DLS) to characterize the average size 
of agglomerates in the dosing media.  A dark-field microscope with Cytoviva as a light 
source and using the Hyperspectral Imaging (HSI) technique was used for verifying that 
the particles are indeed copper particles by analyzing the spectra collected by the 
spectrophotometer.  The Low Voltage Electron Microscope (LVEM), Environmental 
Scanning Electron Microscope (ESEM), Scanning Electron Microscope (SEM) and 
Transmission Electron Microscope (TEM) were used to observe surface morphology 
changes that the particles experience over time while suspended in water, oxidation 
changes on particle surfaces, uptake of particles into N2A cells, and also confirmation of 
sizes as well as any possible changes in particle size over time.  The 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay was used for the assessment of cellular viability based on mitochondrial 
function for the Cu-NP 25 nm, CuO-NP 40 nm, Cu-MSP 500 nm, as well as CuCl2.   
 
3.2 Assumptions 
Several key assumptions were made at the beginning of the laboratory experiments. 
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(1) The properties of Cu and CuO NPs and Cu micron particles were expected to 
change after dry powder particles were suspended in water, dosing and 
growth medias. 
(2) Cells dosed at the same Cu particle concentration were equally exposed 
throughout the experiment and that the exposure method used was 
satisfactorily conducted.  
(3) Studying the toxicity of copper particles using neuroblastoma cells as a model 
has relevance to toxicity of the particles to humans. 
(4) In Vitro results are limited and cannot be directly extrapolated without caution 
to predict in vivo results.   
 
3.3 Cell Line 
The Neuro-2a (N2A) line was obtained from the American Type Culture 
Collection (ATCC).  Clone Neuro-2a was derived by R.J. Klebe and F.H. Ruddle from a 
spontaneous tumor of a strain A albino Mus musculus, or mouse.  These cells are 
adherent type cells, and their morphology is described as neuronal and amoeboid stem 
cells.  The disease that these cells would eventually manifest to would be neuroblastoma 
in the organism.  ATCC product description indicates that this tumor line produces large 
quantities of microtubular protein which researchers believe “play a role in a contractile 
system which is responsible for axoplasmic flow in nerve cells” and that the World 
Organization for Animal Health (OIE) routinely uses these cells for the diagnosis of 
rabies (ATCC, 2011).  These cells were chosen because they provide a neuronal model, 
 
  
bringing a different perspective than the more commonly studied macrophages or 
keratinocytes.   
 
3.4 Cell Culture 
Cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) 
nutrient mixture F-12 Ham’s and supplemented with 10% Fetal Bovine Serum (FBS), 
received from American Type Culture Collection (ATCC, Manassas, USA).  1% 
Penicillin-Streptomycin, received from American Type Culture Collection (ATCC, 
Manassas, USA) was added to the growth media.  DMEM was freshly prepared from 
powder form and preparation instructions were followed from Sigma-Aldrich’s product 
information page (Sigma-Aldrich, DMEM, 201).  Fetal Bovine Serum is widely used as a 
growth supplement for cell culture use mainly due to its high content of embryonic 
growth promoting factors.  From Sigma-Aldrich, “when used at appropriate 
concentrations it supplies many defined and undefined components that have been shown 
to satisfy specific metabolic requirements for the culture of cells” (Sigma-Aldrich, 2011).  
Penicillin-Streptomycin (pen strep) is a broad-spectrum bactericide effective against both 
gram negative as well as gram positive bacteria.  Upon thawing its activity decreases.  
Therefore, it’s best that it is thawed shortly before use (Lonza, 2011).   
 
       3.4.1 Cell Maintenance  
 Cell maintenance was conducted to ensure healthy cells were always available for 
experiments.  Detailed cell care instructions are given in appendices A and B.   
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       3.4.2 Cell Count/Cell Volume 
In order to measure and compare results, and to ensure quality imaging, cells must 
be plated at certain concentrations.  Unless otherwise noted, all cells are plated in 96-well 
plates at 150K cells per mL.  Nexcelom Bioscience’s Cellometer Vision was used for 
automated cell counts.  Samples can also be adjusted to the desired concentration in the 
program (Nexcelom Bioscience, 2011). 
 
3.5 Biotek Synergy HT  
The water-soluble formazan product produced by active mitochondria in live cells 
was quantified with the Biotek Synergy HT plate reader in the MTS assays.  The plate 
reader measured emitted light at 490 nm wavelengths for the MTS assay.  A reading at 
“0” minutes was also taken and then subtracted from the final reading to account for any 
background absorbance due to the nano or micron-sized particles or the solution.  The 
percent reduction of MTS was then compared to the control cells not exposed to 
treatment, which represented 100% of MTS reduction.   
 
3.6 Nanoparticles 
The test materials, Cu-NPs (small metallic Copper nanoparticles 25 nm, small 
oxidized Copper nanoparticles 40 nm in diameter) and Cu micron-sized particles (large 
Copper particles at 500 nm in diameter) were supplied by American Elements.  The Cu 
nano and micron particles, in dry powder form, were suspended in de-ionized water to 
make stock solutions (1 mg/ml).  Prior to each use, stock solutions were sonicated to 
 
  
reduce agglomeration of particles.  Agglomeration was characterized with the Olympus 
IX71 inverted fluorescent microscope with CytoViva as a light source (Appendix G).   
Fresh dilutions were made for each specific experiment from stock solutions and 
the appropriate concentrations were obtained by mixing the appropriate amount of stock 
solution with dosing media.  Details for each copper concentration (dose) are given in 
future sections.  Tables 3 and 4 categorize nanoparticles by source, size, assay use, and 
dosing range. Other dosing concentrations are given specifically for the specific result 
reported in the results section. 
Table 3. Nanoparticles Used 
Chemical Size (diameter) Source  Uses 
Cu 25 nm American Elements Characterization, MTS Assay 
CuO 40 nm Sigma Aldrich Characterization, MTS Assay 
Cu 400 nm American Elements Characterization, MTS Assay 
CuCl2  Novacentrix MTS Assay 
 
 
Table 4. Nanoparticle Dosing (0, 5, 10, 25, 50, 100 µg/mL media) (10% FBS) (1% 
Penicillin-Streptomycin) for MTS Assay 
Particle  0 µg/mL 5 µg/mL 10 µg/mL 25 µg/mL 50 µg/mL 100 µg/mL 
Cu 
25 nm 
3 mL of 
dosing 
media 
15 µL Cu 25 
nm + 2985 µL 
dosing media 
30 µL Cu 25 nm 
+ 2970 µL 
dosing media 
75 µL Cu 25 nm 
+ 2925 µL dosing 
media 
150 µL Cu 25 
nm + 2850 µL 
dosing media 
300 µL Cu 25 nm 
+ 2700 µL dosing 
media 
CuO  
40 nm 
3 mL of 
dosing 
media 
15 µL CuO 40 
nm + 2985 µL 
dosing media 
30 µL CuO 40 
nm + 2970 µL 
dosing media 
75 µL CuO 40 
nm + 2925 µL 
dosing media 
150 µL CuO 40 
nm + 2850 µL 
dosing media 
300 µL CuO 40 
nm + 2700 µL 
dosing media 
Cu   
500 nm 
3 mL of 
dosing 
media 
15 µL Cu 500 
nm + 2985 µL 
dosing media 
30 µL Cu 500 
nm + 2970 µL 
dosing media 
75 µL Cu 500 nm 
+ 2925 µL dosing 
media 
150 µL Cu 500 
nm + 2850 µL 
dosing media 
300 µL Cu 500 
nm + 2700 µL 
dosing media 
CuCl2 3 mL of 
dosing 
media 
15 µL CuCl2 + 
2985 µL 
dosing media 
30 µL CuCl2 + 
2970 µL dosing 
media 
75 µL CuCl2  + 
2925 µL dosing 
media 
150 µL CuCl2 + 
2850 µL dosing 
media 
300 µL CuCl2 + 
2700 µL dosing 
media 
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3.7 MTS Assay 
The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium (MTS) assay is a colorimetric method for the assessment of cellular 
viability based on mitochondrial function.  The assay consists of the novel tetrazolium 
compound and an electron coupling reagent phenazine methosulfate (PMS).  Cells 
bioreduce the MTS into a formazan product that is tissue culture soluble.  This chemical 
conversion process can be seen in figure 3-1 below.  The absorbance of the formazan 
product was measured at 490 nm directly from the 96-well assay plates.  
 
 
Figure 4. Structure of MTS tetrazolium salt and the formation of the Formazan product. 
(“Cell Titer 96® Aqueous Non-Radioactive Cell Proliferation Assay”, Promega, 2009). 
 
 
Four 96 well plates of N2A cells were treated with the three types of Cu particles 
as well as CuCl2.  The same amount of dosing media was placed in cell wells to be used 
as controls.  After 180 minutes of treatment and incubation with the copper particles the 
MTS was added to all the cell wells.  At “0” time a reading was taken at 490 nm as a 
 
  
background.  After an hour of incubation with the MTS agent, a dark purple color 
developed within the cells, indicating the formation of a water-soluble formazan product 
by active mitochondria in live cells. The formazan product was quantified with a 
microplate reader at 490nm. A “0” minute reading was then subtracted out of the final 
reading to account for background absorbance due to the NPs or the solution. The percent 
reduction of MTS was compared to controls (cells not exposed to particles), which 
represented 100% MTS reduction.  
The MTS experiment was then repeated, but this time with a 1 hour pre-treatment 
with the endocytosis inhibitor Dynasore.  More information on Dynasore can be found in 
section 3.8.5 along with the Dynamic Light Scattering technique.  This experiment was 
conducted in order to eliminate con-founders and determine whether pre-treatment with 
Dynasore can increase cell viability prior to Cu exposures.    
 
 
 3.8 Characterization 
 
     Characterization of the copper particles was conducted in a series of phases using 
different techniques.  The goal of characterization was to study particle morphology and 
surface oxidation in “dry” as well as “wet” conditions.  A series of techniques were used, 
beginning with the Low-Voltage Electron Microscope (LVEM) and proceeding to the 
Environmental Scanning Electron Microscope (ESEM), the Scanning Electron 
Microscope (SEM), the high resolution Transmission Electron Microscope (TEM),   
Dynamic Light Scattering (DLS), and finally Hyperspectral Imaging (HSI), in turn. 
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       3.8.1 LVEM 
Low Voltage Electron Microscopy was conducted for the Cu-NP 25 nm, CuO-NP 
40 nm, and Cu-MSP 500 nm.  The LVEM is designed for a broad range of applications in 
many fields to include biology, medicine and material science and provides valuable 
capabilities in nanotechnology and organic materials.  High contrast is achieved by using 
much lower electron energy at 5 keV compared to the high resolution TEM and as a 
result there is additional electron scattering resulting in better contrast (Schrand and 
Hussain, 2010).   
The LVEM was used as a basic tool to observe the particles and provide an 
estimate of the sizes of the particles.  It serves as a preliminary scan and gives a basic 
view of the general shapes of the particles.  The LVEM is under high vacuum but uses 
low voltages.  The table-top set up also provides for ease of use. 
 
       3.8.2 ESEM 
 The ESEM was used to better observe morphology.  It is a unique instrument as 
the samples can be studied with it while they are somewhat “wet”.  Limited surface 
morphology can be observed.  The ESEM permits increased magnification of images but 
operates under low vacuum conditions.  
 
       3.8.3 SEM 
 An experiment evaluating N2A cells exposed to various copper particles as well 
as CuCl2 was conducted.  The N2A cells were seeded on glass cover slips and allowed to 
grow for about 24 hours or when they looked fairly confluent and healthy.  Samples were 
 
  
then exposed to the particles or CuCl2 for 3 hours and then washed and dried.  Samples 
were then prepared for imaging at the Materials Lab.  Further details on this protocol can 
be found in appendix E. 
 
       3.8.4 TEM 
Dry characterization was conducted using the high resolution TEM.  Cu 
Nanoparticles (Cu-NPs) (25 nm), Cu micron-size particles (Cu-MSPs) (500 nm) and Cu 
Oxide Nanoparticles (CuO-NPs) (40 nm) were freshly suspended in water and prepared 
for TEM imaging at the “0” time point.  Samples of each type of particle were then 
imaged again at a short term incubation time point (2 or 3 months) and again at a long 
term incubation time point (6 months).  This incubation time point imaging was 
conducted in order to look for general morphology changes, as well as surface 
morphology changes and surface oxidation changes.   
 
       3.8.5 Dynamic Light Scattering 
Prior to any experimentation with the N2A cells, it was important to learn about 
the behaviors of the particles in dosing media, replicating the conditions the cells would 
experience while being dosed.  In order to understand biochemical interactions, it was 
necessary to investigate solution agglomeration of particles.  Agglomeration of particles 
may interfere with cellular uptake by processes such as phagocytosis or pinocytosis.  To 
eliminate possible confounding factors due to bio-molecule size, only dosing solution 
(without FBS) was added to formulate solutions for measurements. 
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To do this, Malvern’s Zetasizer was used to conduct dynamic light scattering of 
the Cu particles.  In order to understand whether the cells would uptake the particles, it is 
necessary to study particle behavior and agglomeration in just the dosing media alone as 
large agglomerates would not be able to cross the cell membrane.  The Zetasizer DLS 
instrument measures particle size by looking at the diameter of the sphere that diffuses at 
the same speed as the particle being measured.  The instrument first measures the 
Brownian motion of the particles and then interprets this data using the Stokes-Einstein 
equation to determine the relationship between the size of the particle and its speed due to 
the Brownian motion.  The particles are in constant motion, and the speckle pattern that is 
created will also appear to move.  Constructive and destructive phases of the scattered 
light will in turn cause bright and dark areas.  These areas grow and diminish in intensity 
and will appear to fluctuate.  The DLS system measures this rate of fluctuation and uses 
this information to calculate the size of the particles (Malvern Zetasizer Manual, 2009).   
The Cu particles were freshly prepared from stock solutions to arrive at final 
concentrations of 25 ug/mL, 50 ug/mL and also 100 ug/mL and added to 25 µM of 
Dynasore, an endocytosis inhibitor.  Dynasore, an endocyctosis inhibitor, is co-incubated 
with the particles because current research shows that it may potentially aid cell viability 
while the cell is dosed with Cu nanoparticles (Schrand et al., In Preparation).  
Specifically the addition of Dynasore increases viability of cells dosed with metallic 
forms of Cu at high doses (>50 µg/ml).   
From studies conducted by Schrand et al. (In Preparation), it was discovered that 
both small and large metallic Cu- NPs are more toxic than the CuO-NPs.  Additionally, 
CuO-NPs are not toxic after 3h of exposure and are also not affected by the presence or 
 
  
absence of the endocytosis inhibitor.  This observation poses the possibility that if the 
chemical modulator can affect the N2A cells in some way, either by preventing the 
particles from being up-taken or changing the shape or size of the particles, then the 
cytotoxicity of the Cu particles are lessened on the cells.  In this research, it is reasonable 
to suggest that any alterations in physiochemical properties after incubation with 
Dynasore would therefore be apparent.    
It was also shown that the manufactured nanoparticles were not always in the size 
ranges claimed.  For Cu-NP “25 nm” was measured to have an average size of 88 ± 
30nm, CuO-NP “40 nm” was measured to have an average size of 78 ± 21nm, and Cu-
MSP (500 nm) had an average size of 477 ± 184nm (Schrand et al., In Preparation).  
However, for the experiments described here the original manufactured sizes will be used 
to designate the particles, but with the understanding that the nominal size does not 
represent the actual size.   
3-Hydroxynaphthalene-2-carboxylic acid (3,4 dihydroxybenzylidene) hydrazide, 
or Dynasore, is a non-competitive inhibitor of dynamin 1, dynamin 2 and mitochondrial 
dynamin (Drp1) GTPase activity.  Dynamin is essential for clathrin-dependent coated 
vesicle formation and is “required for membrane budding at a late stage during the 
transition from a fully formed pit to a pinched-off vesicle” while Dynasore is able to 
block the endocytic pathways that are dependent on dynamin and blocks vesicle 
formation within seconds of being added (Macia et al., 2006).   
Figure 3-2 shows the chemical structure of Dynasore.  Previous experiments 
showed that there was a limited increase in viability of cells that were pre-treated with 
Dynasore prior to NP exposure (Schrand et al, In Preparation).   
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Fig 5. Chemical structure of Dynasore (Tocris Bioscience, 2010). 
 
       3.8.6 Hyperspectral Imaging (HSI) using Cytoviva®  
The Hyperspectral Imaging system using Cytoviva as a light source provides a 
spectral analysis of nanomaterials in the visible near infrared spectral range (VNIR), from 
400 to 1000 nm.  While not used in this research, the HSI system can analyze for both 
non-fluorescent and fluorescently labeled components in live cells and nano-materials, 
enabling a wide range of capabilities for bio-medical research in both cell biology and 
infectious disease research (Cytoviva, 2011).   
Hyperspectral Imaging (HSI) was conducted on control N2A cells as well as on 
each of the three particle types (Cu-NP 25 nm, CuO-NP 40 nm, Cu-MSP 500 nm).  
Copper nano and micron-sized particles scatter colored light when illuminated with white 
light (the Cytoviva light source).  A concentric imaging spectrophotometer collects the 
spectra from each particle type.   
 Many metallic nanoparticles are able to support surface plasmons at optical 
frequencies.  These plasmons are known as localized surface plasmons (LSPs).  It is due 
to the recent understanding of the nature of these plasmons combined with their refractive 
index sensitivity that has led to using nanoparticles as biosensors (Miller and Lazarides, 
2005).   
 
  
 When a particle is struck by an electromagnetic wave, the electrons of the particle 
will oscillate at the frequency of the incident wave and an oscillating electron will radiate 
at the same electromagnetic radiation as the oscillating electron.  It is from this secondary 
radiation that the scattering of light occurs.  Since light scattered by a particle illuminated 
from a monochromatic light source has the same wavelength as the incident light the 
distinct scattered colors coming from different particles and varying sizes can only be 
produced when the source (illuminating) light is a polychromatic white light.  This 
polychromatic white light is “produced by a filament lamp operated at high color 
temperature” and the scattering of colors results because each type of particle will 
preferentially scatter light over a narrow wavelength band.  Nanoparticles differing in 
composition, shape, size, and homogeneity as well as their medium refractive index will 
alter the respective particles’ light-scattering properties (Yguerabide and Yguerabide, 
1998).   
Yguerabide and Yguerabide (1998) show that copper particles display a weak 
scattering band around the 380 to 550 nm region in Table 5.  This can also seen in Fig 3-
3, where “the light-scattering power of a particle can be expressed in terms of the light-
scattering cross section” versus the various wavelengths from light scattered by various 
particles (Yguerabide and Yguerabide, 1998).   
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Fig 6. Graphs of light-scattering cross section vs. wavelength for various particles.  
(Yguerabide and Yguerabide, 1998). 
 
 
   
 
Table 5. Calculated Light-Scattering and Absorption Properties for Various Particles 
(Yguerabide and Yguerabide, 1998). 
 
 
 
 
 
  
3.9  Statistical Analysis 
 
 Statistical Analysis was performed for the MTS data as mean ± standard 
deviation.   
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IV.   Data Description and Analysis 
 
4.1 Introduction 
 
This Chapter presents the data gathered from the methodologies described in  
Chapter 3.  The chapter includes, in this order: 24 hour exposure MTS data of N2A to 
Cu-NPs, Cu-MSPs and CuO-NPs, and CuCl2, DLS experimental data, LVEM images, 
ESEM images, SEM images, TEM images at various time-points and HSI with Cytoviva.    
 
4.2 MTS data 
MTS was performed on the three types of Cu particles and CuCl2.  The results of 
This cellular proliferation assay can be seen in Fig 4-1.   
 
Fig 7. MTS assay for the three types of Cu particles and CuCl2. (Concentration in µg/mL 
for NPs and µM for CuCl2) 
 
 
  
In terms of cellular viability, CuCl2 is the least toxic at all concentrations.  Cu-NP 
25 nm is less toxic at low concentrations (< 25 µg/mL) than Cu-MSP 500 nm and CuO-
NP 40 nm.  At concentrations above 25 µg/mL, Cu-NP 25 nm becomes comparable in 
toxicity to CuO-NP 40 nm and more toxic than Cu-MSP 500 nm.  From further 
characterization, it is not surprising that the Cu-NP 25 nm and CuO-NP 40 nm share 
similar toxicities.  As these two particles become suspended in water for longer periods 
of time, they both become oxidize, especially Cu-NP 25 nm, which may explain the 
similarities in toxicities.   
 
 
4.3 Dynamic Light Scattering Experiments 
Dynamic Light Scattering Experiments were conducted in order to observe  
changes in the dynamic size of Cu-NPs, CuO-NP, and Cu-MSP under cell culture 
conditions.  An initial trial of DLS was conducted for the particles at 50 µg/mL 
concentration with dosing media.  The general conclusion is that at these conditions there 
is a trend for the Cu particle sizes to increase.  The surprising aspect of size observation 
in solution is that it follows an inverse trend compared to the primary size of the particles: 
CuO-NPs > Cu-NPs > Cu-MSPs (Schrand et al., In Preparation).   
 Previous studies show limited cellular modulation with co-incubation with 
Dynasore.  An initial experiment was conducted to serve as a control for change in 
particle agglomeration for the Cu-NP (25 nm), CuO-NP (40 nm), and Cu-MSP (500 nm) 
with 3, 6, and 24 hour incubation times without the use of the endocytosis inhibitor 
Dynasore.  Cu particles were freshly diluted from 1 mg/mL stock solutions prior to 
readings.  Table 6 shows concentration and incubation times.  In general agglomerations 
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became larger as incubation time increased from 3 to 24 hours with the exception of the 
Cu-NP 25 nm.  Dynamic sizes of the particles under cell culture conditions are CuO-NPs 
> Cu-MSPs > Cu-NPs, which is similar to the sizes measured earlier by Schrand et al.  
 
Table 6. Concentration and incubation times used for DLS control experiment without 
Dynasore 
 
Sample & 
concentration 
Cu particle volume, 
dosing media volume 
0 hour 
incubation 
3 hour 
incubation 
24 hour 
incubation 
Cu-NP (25 nm) 
25 µg/mL 
25 µg/mL Cu 
975 µL dosing media 
0 hour 
incubation 
3 hour 
incubation 
24 hour 
incubation 
CuO-NP (40 nm) 
25 µg/mL 
25 µg/mL Cu 
975 µL dosing media 
0 hour 
incubation 
3 hour 
incubation 
24 hour 
incubation 
Cu-MSP (500 nm) 
25 µg/mL 
25 µg/mL Cu 
975 µL dosing media 
0 hour 
incubation 
3 hour 
incubation 
24 hour 
incubation 
 
 
Figures 8A, 6B, and 6C show the results of this initial DLS experiment. 
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The next set of DLS experiments involve three trials of Cu-NP, CuO-NP, and Cu- 
MSP in dosing media at three different concentrations of 25 µg/mL, 50 µg/mL, and 100 
µg/mL as seen in Table 7.  Measurements were taken at 0 and 3 hours for each particle at 
each concentration.  25 µM of the endocytosis inhibitor Dynasore was also added to each 
sample because ultimately the goal is to understand if the chemical has any effect on the 
viability of the N2A cells as seen in previous studies.   
 
Table 7. Cu particle, Dynasore and dosing media volumes 
 
Final concentration for 
samples 
Cu particle volume Dynasore 
volume 
Dosing Media Total Volume 
25 µg/mL Cu particle + 
25 µM Dynasore 
25 µL 25 µL 950 µL 1000 µL 
50 µg/mL Cu particle + 
25 µM Dynasore 
50 µL 25 µL 925 µL 1000 µL 
100 µg/mL Cu particle + 
25 µM Dynasore 
100 µL 25 µL 875 µL 1000 µL 
 
 
Figures 9A through 9I show size distributions from this DLS experiment. 
 
 
  
 
Fig 9A. Size distribution of Cu particles at a concentration of 25 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 1st trial 
 
 
 
 
Fig 9B. Size distribution of Cu particles at a concentration of 25 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 2nd trial 
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Fig 9C. Size distribution of Cu particles at a concentration of 25 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 3rd trial 
 
 
 
 
 
Fig 9D. Size distribution of Cu particles at a concentration of 50 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 1st trial 
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Fig 9E. Size distribution of Cu particles at a concentration of 50 µg/mL and 
Dynasore at both 0 and 3 hours of incubation,2nd trial 
 
 
 
 
Fig 9F. Size distribution of Cu particles at a concentration of 50 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 3rd trial 
 
600
800
1000
1200
1400
1600
1800
2000
2200
2400
2600
0 hours 3 hours
Si
ze
 (n
m
)
50 ug/mL - 2nd Trial + Dynasore
25 nm Cu
40 nm Cu 
400 nm Cu 
600
800
1000
1200
1400
1600
1800
2000
2200
2400
2600
0 hours 3 hours
Si
ze
 (n
m
)
50 ug/mL - 3rd Trial + Dynasore
25 nm Cu
40 nm Cu 
400 nm Cu 
 53 
 
Fig 9G. Size distribution of Cu particles at a concentration of 100 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 1st trial 
 
 
 
 
Fig 9H. Size distribution of Cu particles at a concentration of 100 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 2nd trial 
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Fig 9I. Size distribution of Cu particles at a concentration of 100 µg/mL and 
Dynasore at both 0 and 3 hours of incubation, 3rd trial 
 
 
4.4 LVEM Imaging 
In Fig 10 A-C, LVEM images of the three particles are shown.  The LVEM may 
not produce the sharpest images but the process is not time consuming or difficult to set 
up.  From these images basic particle morphology and agglomeration behavior can be 
observed.   
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Fig 10A. Cu-NP 25 nm at 202 kx magnification 
 
 
  
 
Fig 10B. CuO-NP 40 nm at 202 kx magnification 
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Fig 10C. Cu-MSP 500 nm at 202 kx magnification 
 
4.5 ESEM Imaging 
Environmental Scanning Electron Microscopy was conducted on Cu-NPs, CuO-
NPs, and Cu-MSPs 3 months after suspension in water.  The particles were diluted from 
stock solutions and the goal of the microscopy was to aid in the characterization of the 
physiochemical properties of the particles themselves.  Examination of surface roughness 
is an indicator of the amount of oxidization the particles experience and may elucidate 
particle uptake sizes.  Figures 11A-B illustrate the original images captured. 
 
  
 
                   Fig 11A. Cu-NP 25 nm at 3 months 
 
 
 
                  Fig 11B. CuO-NP 40 nm at 3 months 
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4.6 SEM Imaging 
SEM images were taken after N2A cells were dosed with Cu particles in an 
experiment to visually determine the placement of particles and cells in dosing media.  
All particles were dosed at a concentration of 25 µg/mL.  Fig 12A-D show a series of 
images including a control image and that of the three particles. 
 
 
Fig 12A. Control image without Cu-NPs 
(Image taken by Dr. Amanda Schrand) 
 
 
  
 
Fig 12B. Cu-NP 25 nm 
(Image taken by Dr. Amanda Schrand) 
 
 Although some charging is seen in the image, the Cu-NP 25 nm can be seen fairly 
clearly with the N2A cells showing up as darker shadowy figures.  In scanning electron 
microscopy, charging effects are described where excess negative charge accumulates on 
the specimens and image artifacts arise from excess surface charge and produce poor 
images.  At times it may be necessary to prepare poorly conducting specimens with a 
metallic coating such as gold (Shaffner and Van Veld, 1971).   
The control image shows the cells without any Cu NP dosing, and the cells are 
observed be more adherent and neuron like with more dendrites present.  As the N2A 
cells are dosed with the Cu particles they are under more oxidative stress and thus start to 
become rounder and less adherent to the glass cover-slip surfaces.   
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Fig 12C. CuO-NP 40 nm 
(Image taken by Dr. Amanda Schrand) 
 
Fig 12D. Cu-MSP 500 nm 
 
  
(Image taken by Dr. Amanda Schrand) 
 
4.7 TEM Imaging  
TEM Imaging was conducted on the Philips Lab 6 TEM at the AFRL Materials 
Laboratory.   The following figures show the morphology and sizes of the particles 
suspended in water: initially after preparation, at 2 or 3 months after preparation, and 
again at 6 months.  The surface oxidation, agglomeration, and sizes indicate changes the 
particles experience over time.    
 It is worth noting that initial TEM imaging was conducted along with a brief 
study on the size distribution of the particles.  Interestingly, as was also found in the 
study by Schrand et al. (In Preparation) referred to earlier, the Cu-NP 25 nm has a larger 
average size than the CuO-NP 40 nm.  This is important to realize; nominal sizes 
provided by the manufacturer may not be indicative of the true particle size.  The stock 
particles, in powder form, are preserved under Argon gas, but even so, properties of the 
particles may change over time.   
 The three different types of particles were imaged again after 2 or 3 months to 
look for any changes in oxidation, morphology, and overall surface properties.  Fig 13A-
C show images of the three types of particles.   
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      Fig 13A. Cu-NP 25 nm at 2 months 
 
 
 
      Fig 13B. CuO-NP 40 nm at 3 months 
 
 
  
 
 
 
     Fig 13C. CuO-MSP 500 nm at 3 months 
 
 
 Figures 14, 15, and 16 show the comparison images of the three particles at 6 
months.  Comparison images were taken at standard magnifications of 3800x, 8800x, 
15000x, 50,000x, and 80,000x so improved observations can be made.   
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Fig 14. Cu-NP 25 nm at 6 months 
  
          Fig 14A. 3800x                       Fig 14B. 8800x 
 
       
                   Fig 14C. 15,000x                                Fig 14D. 50,000x 
 
 
  
 
Fig 14E. 80,000x 
 
Fig 15. CuO-NP 40 nm at 6 months 
       
                    Fig 15A. 3800x              Fig 15B. 8800x 
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                   Fig 15C. 15,000x                                Fig 15D. 50,000x 
 
 
Fig 15E. 80,000x 
 
 
 
 
 
  
Fig 16. Cu-MSP 500 nm at 6 months 
      
                  Fig 16A. 3800x                      Fig 16B. 8800x 
 
      
                  Fig 16C. 15,000x                    Fig 16D. 50,000x 
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Fig 16E. 80,000x 
 
4.8   Hyperspectral Imaging  
Hyperspectral Images and spectra.  
   
Fig 17A. HSI image of Cu-NP 25 nm with Spectral Profile. 
 
  
   
Fig 17B. HSI image of CuO-NP 40 nm with Spectral Profile 
 
   
Fig 17C. HSI image of Cu-MSP 500 nm with Spectral Profile 
 
Unfortunately, it was also shown that copper does not have a “prominent light-
scattering or absorption peak in the visible region of the spectrum” (Yguerabide and 
Yguerabide, 1998).  This makes it very difficult to draw any conclusions from the HSI 
data as there is not a clear plasmonic peak for copper and the collected spectra of 
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dissimilar sizes of copper nano and micron-sized particles would not give much 
information.   
Careful inspection of the three spectral profiles shows that there are very broad 
peaks and it is difficult to pinpoint any specific peaks.  From chapter 3, Yguerabide and 
Yguerabide (1998) show that the copper band should fall somewhere between 380-530 
nanometers, yet these spectra show broad bands between 500-800 nanometers.  This 
could be due to agglomeration of the particles but regrettably no additional information is 
provided such as oxide content between the various particles as no clear “shift” can be 
observed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
V.   Conclusions and Future Research Considerations 
 
5.1 Overview 
This chapter summarizes the results of this research and suggests additional 
studies that may aid to further characterize Cu-NPs, Cu-MSPs and CuO-NPs.  
Suggestions for methodology improvements are discussed as well as further additional 
research that may aid in better characterization.   
 
5.2 Conclusions 
This research compared the effects upon N2A cellular viability by the three types 
of Cu particles and characterized these particles using a variety of techniques.  Toxicity 
changed for the N2A cells at different concentrations and for different particles.  At high 
concentrations, N2A cells fared better when dosed with Cu-MSP 500 nm.  This may be 
related to cellular mechanisms where cellular uptake is generally limited for large 
particles around 500 nm, thus enabling smaller Cu particles to be uptaken easier.  
Characterization showed a general increase in size when the particles were incubated 
with the endocytosis inhibitor Dynasore.  This may also explain apparent “rescue” effects 
seen in previous research, where there was increased cellular viability in the presence of 
Dynasore.  At higher concentrations of particles (100 µg/mL) with 25 µM Dynasore 
trends are somewhat more inconclusive, suggesting possible interferences in the solution 
or between the particles themselves as far as forming agglomerations.    
Additionally, this research seeks to observe in vitro effects upon murine 
neuroblastoma cells (N2A) by these three types of particles as well as by CuCl2.  
Microscopy techniques indicate observable changes in oxidation for Cu-NP 25 nm and 
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CuO-NP 40 nm after suspension in water over long incubation.  In general, 
agglomerations of the particles increase when dosed with the endocytosis inhibitor 
Dynasore.  In terms of cellular viability, CuCl2 is the least toxic at all concentrations.  
Cu-NP 25 nm is less toxic at low concentrations (< 25 µg/mL) than Cu-MSP 500 nm and 
CuO-NP 40 nm.  At concentrations above 25 µg/mL, Cu-NP 25 nm becomes comparable 
in toxicity to CuO-NP 40 nm and more toxic than Cu-MSP 500 nm.    
 
5.2.1 Imaging 
 
Various techniques for imaging cells and toxicity studies were conducted with the 
nano and micron-sized particles.  A general rough estimate of sizes and morphology was 
conducted with the LVEM.  More detailed imaging was conducted with the ESEM and 
SEM.  Finally the high resolution TEM was used to look at changes in surface 
morphology, oxidation and size over time.  DLS was also used to estimate the 
agglomeration of the particles while dark field microscopy with Cytoviva as a light 
source provided insight on particle uptake and provided particle spectral profiles.  Each 
of these techniques was useful in directing the focus of this research and providing 
insights, but each technique also had its own limitations.   
The ESEM imaging, though not very successful, was used to gain more 
information on general particle morphology.  Image quality and instrument availability 
was problematic, but a few images did show likely nanoparticle agglomerations on the 
surface of the ESEM stub.  Additional technique modifications with ESEM may be 
helpful for future research.  SEM imaging with the cells gave good morphological 
indications of healthy cells as more rounded than those receiving increasing doses of Cu 
 
  
particles and proved qualitatively that the technique worked well.  TEM imaging, though 
the most time consuming and very difficult to schedule for, was critical in determining 
particle morphology and had the best results.  Previous studies show very low, if any Cu 
particle uptake into N2A cells and future studies may be needed in order to determine 
particle locations in respect to the N2A cells and overall changes in N2A morphology 
after Cu particle exposures (Schrand, In Preparation).   
 
5.3 Recommended Additional Research 
 
5.3.1    Characterization and Exposure 
Characterization may have been affected by other experimental conditions that 
may have interfered with the results.  Vortexing of the particles was consistent prior to 
dosing or experimentation, but sonication of the particles was not.  Sonication of particles 
may have immense effects on their properties so sonication should be conducted more 
carefully and consistently in the future.   
Other techniques that are emerging such as the separation of the Cu metal and the 
Cu ions can prove to be helpful in determining whether the cellular toxicity is due to the 
actual metal or the corresponding ions.  This will also enable other techniques to 
determine the quantity of Cu that is released into the cell medium for exposure studies. 
More repetitions on the DLS can be conducted to try to find better trends in 
particle agglomeration sizes and behaviors in solution.  The endocytosis inhibitor 
Dynasore previously demonstrated to increase cellular viability is still inconclusive and 
need to be further explored as to exactly what are the potential mechanisms for reducing 
cytotoxicity for N2A cells. 
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Appendix A: General Maintenance and Toxicity Testing of N2A Cell Line  
(Schrand & Hussain, 2005) 
 
PURPOSE/PRINCIPLE:  This standard operating procedure describes the in vitro 
methods for maintaining N2A (neuroblastoma cells) for toxicity testing procedures 
including formulations for MTS.   
 
KEY WORDS:  N2A, neuroblastoma, cell culture, in vitro, nanotoxicity. 
1.     SAFETY AND OPERATING PRECAUTIONS: 
 1.1 Practice aseptic technique and work with all cells and solutions under the 
biological hood.  
 1.2 Wear appropriate gloves, eye goggles and lab coat when handling 
hazardous materials. 
 1.3 Properly dispose of unused/spent toxic materials (nanoparticles). 
2.    EQUIPMENT/MATERIALS/REAGENTS: 
2.1 Culture media (DMEM/F12 (Sigma powder), 10% fetal bovine serum 
(FBS), and 1% antibiotics (Pen/Strep)  
*Note: discard if pink (too acidic) or orange (too basic)…should be 
red/orange in color 
 2.2 Flasks, plates, slides for growing cells  
 2.3   Trypsin for detaching adherent cells 
 2.4  Acidified IPA with 70% isopropanol for dissolving cells 
300mL 70% IPA and 1.64mL conc. HCl 
 
  
 2.5   MTS (C18H16N5SBr, Cat#M2128 Sigma) 
200 mg MTS (in freezer, Rm 169), 40ml PBS, mix on stir plate for ~15 
minutes, store covered in foil due to light sensitivity, dated, good for 2-4 
weeks 
 2.6 Nanomaterials with a known concentration typically diluted in water for a 
stock solution of concentration 1-10 mg/ml 
 2.7 Olympus IX71 Inverted Microscope with 12 bit QICAM from IMAGINE 
(Lab 160) 
SPECIMEN/SAMPLE:  Seed cells at high enough density to achieve 80% confluency 
by time of treatment.  For example, if you are seeding on Friday and want to treat 
on Monday (3 days of growth time), seed at 200-300K cells/mL.  If you are 
seeding on Monday and want to treat on Tuesday (24h of growth time), seed at 
500-600+ K cells/mL.  For better imaging conditions of individual cells, seed at 
100-250K cells in 1 mL of culture media.   
*Note:  Check cells before dosing to optimized for your cells.  If you are 
performing an MTS assay and you expose them before they are confluent, your 
“intensity” of blue color will be very low and you won’t get readings.  The more 
cells you have, the more “blue” will develop/stronger your “signal.” 
3. PASSAGING CELLS 
4.1  Use 1-2 mls of 1% trypsin to release cells from the bottom of cell culture 
flasks.  Avoid tapping if clumps form.   
*Note:  N2A cells are a mixture of floating and adherent cells 
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4.2  Add 5-10 mls of growth media containing serum to neutralize the effect of 
the trypsin and transfer this solution to a conical vial before performing a cell 
count.     
4.3  To get an average cell count, 10 µl of cells in media were added to a 
 hemocytometer slide.  This slide contains numerous grids that are used to help 
 count cells.  The cells located in the grids on each corner of the slide are counted, 
 and the average number of cells in each grid is determined to be the number of 
 cells per 10 µl and, by multiplying that number by 10,000, the number of cells per 
 mL is determined.  The total number of cells in a sample can be determined by 
 multiplying the cells/mL by the number of mL in the sample.  The concentration 
 can be adjusted down by diluting the sample, using the following equation  
Cinitial x Vinitial  =  Cdesired x Vdesired. 
4.4 Based on cell count add media to the cell suspension to obtain the desired 
number of cells for the flask, plate, or slide, then add the correct amount of 
solution to each well/slide. 
4.5  From the remaining solution, add 1mL of cell suspension to a new flask 
containing ~10-12mL media for re-growth, then return the flask to the incubator 
4.6  Change media and reduce cell count every 2-4 days  
5.  NANOPARTICLE DOSING PROCEDURE: 
 5.1   Make nanoparticle dosing concentrations from stock concentrations of 
 nanoparticles in water into fresh in DMEM/F12 media without serum.  If you  
 want to obtain images of these dosing solutions, use 15 mL conical tubes, small 
 
  
clear plastic eppendorf tubes, or glass vials.  Before dosing, mix the solutions well 
by vortexing and pipetting.   
5.2  N2A cells are typically dosed 24 hours after seeding as described in Section 4 
for passaging the cells.  The existing growth media is aspirated prior to the 
addition of nanoparticle solutions.   
5.3  Doses for nanoparticles are typically 0, 5, 10, 25, 50, 100 µg/ml.  Doses for 
bulk materials are typically lower such as AgNO3:  0, 0.5, 1, 2.5, 5, 10µg/ml or 
Mn acetate:  0, 1, 2.5, 5, 10, 25µg/ml.  For 6-well plates, 1ml of dose per well, for 
12 or 24-well plates, 0.5ml of dose per well. A typical 6-well plate set up is as 
follows: 
0 (control) Conc. 1 Conc. 2 
Conc. 3 Conc. 4 Conc. 5 
 
Perform assay in triplicate (3 plates each). 
5.4  After dosing, label wells with dose and label plate with material used and the 
time, then return plates to incubator 
5.5  Following 24 hours (or other time point eg. 12, 48 etc) assay plates for 
determined endpoint (MTS, LDH, etc) 
6.  MTS ASSAY OF VIABILITY 
6.1  Following exposure interval, do NOT aspirate media.  Add MTS stock 
directly to each well:  
6 well plates = add 200 µl of MTS 5 mg/ml stock soln. 
 12 well plates = add 100-150 µl of MTS 5 mg/ml stock soln. 
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24 well plates = add 100 µl of MTS 5 mg/ml stock soln. 
96 well plates = add 200 µl of MTS 5 mg/ml stock soln. 
6.2 Incubate at 37° C in incubator until color develops (usually 30 minutes or may 
be longer) 
6.3 Remove the MTS solution and lyse cells with 0.5 ml acidified isopropanol 
solution (acidified IPA) solution to well and place on a stir plate for 
approximately 30 minutes. 
6.4 Remove the solutions and place into eppendorf tubes to vortex to obtain 
homogeneous staining of the formazan crystals 
6.5  Centrifuge the purple solution at high speed to spin out nanoparticles. 
6.6 Transfer 200 ul of samples into wells of 96 well plate in duplicate or greater 
6.7 Read plates at 570 nm minus 630 nm on a microplate reader  
6.8  For the Molecular Devices SpectraMax190, follow the instructions below: 
Start, Programs, Softmax 3.1, Spf (click), open old file, click template, highlight 
old data, clear, highlight cells, enter group name ie.  control, what it is, sample 0, 
25, etc. for concentrations Turn on microplate reader machine (needs a minute to 
calibrate), drawer will open, snap plate in place, click read, normal, ok, replace.  
Turn off microplate reader and log-out/turn off computer.  Throw away materials 
into red trash can for biohazard. 
6.9  MTS DATA ANALYSIS/RECORDS:   
CT = 100 * ((ODt/ODc) 
CT =  % of MTS reducing activity  
ODt= Optical Density of treated samples 
 
  
ODc= Optical Density of control 
7.  IMAGING FOR NANOPARTICLE UPTAKE 
7.1  After plating and dosing cells as described above, remove nanoparticles and 
wash 1-2X with PBS if necessary.   
7.2  Remove the chambers from slide if necessary and mount with a coverslip, 
then seal edges with clear nail polish 
7.3  Mount slide inverted onto microscope, then focus image. 
7.4  Once your image is in focus through the microscope binocular lenses, start 
the QCapture program.  Press the camera icon, then preview.  To adjust the 
brightness of the image, change the exposure slide bars.  After your preview 
image is adjusted for focus and brightness, make sure acquisition is set to 1x1, 8-
bit B&W, or 24 bit RGB, then press snap to capture image.  Go to File, Save as to 
save image.  Do not use any symbols including periods in your file name and save 
original files as tif.  
 7.5  To add scale bars, press the micrometer icon and select the appropriate  
 magnification.  For 20x images, use 20 micron bar, for 60x images, use   
 100 micron bar.  Right click to burn micron bar onto file.   
8.  QUALITY CONTROL 
  7.1   Use a positive and negative control, examine cells for viability 
(ie.  Control with no nanoparticles and toxic material such as AgNO3 or 
CdO).    
 
LIMITATIONS OF PROCEDURE: 
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8.1   This procedure can be slightly modified for non-adherent cells and cell-
specific media should be used.      
9.    PROCEDURE NOTES:  Too many or two few cells may skew the results of the 
MTS assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix B – Basic N2A Cell Maintenance 
1. Spray alcohol on gloves and on the work space area in the hood to avoid 
contamination! 
2. Cells are observed under light microscope to see how healthy they look and whether 
they are becoming fairly confluent (getting crowded).  If this is the case then it is time to 
split them or plate them. 
3. Aspirate old media with the vacuum but be careful not to remove the cells that are 
adherent to the flask. 
4. Add new GROWTH media (~5-10mL).  This is the DMEM F12K Ham's + 1% 
pen/strep AND 10% FBS. 
5. Scrape the bottom gently with a cell scrape to remove cells that are sticking to the 
bottom. 
6. Mix the media around and then put all of the media along with the cells into a conical 
vial with the 10mL glass pipette.  A 50mL conical vial usually works well for holding the 
media with the cells. 
7. If cells are needed to plated at a certain density, the Nexcelom Bioscience’s Cellometer 
Vision was used for automated cell counts.  Dilutions can be easily calculated to plate at 
desired densities.   
8. Add desired mL of cells into each container (flask, 96-well plate, chambered slides, 
etc).  For 96-well plates, 200uL is added per well with a multi-chambered pipette.  1mL 
of cell solution is added per chamber.  Leftover cell solution is divided into the T-75 
flasks for continued growth.  Cells can be diluted with extra growth media.  If cells are 
 83 
only split, extra cells can be discarded or put into another T-75 flask for growth9.  For 
flasks, make sure to add enough growth media so that each one has ~10-15mL. 
9.  Be sure to observe the cells under the light microscope after they are put into the 
flasks.  They will not have adhered to the bottom of the flasks yet so they will look 
rounder.  Cells need to stay as healthy as possible for experiments.  They will most likely 
need to be split about every 3 days.  Beyond this they may become too confluent and thus 
less healthy. 
10.  Put everything back into the incubator and close the inner door securely.   
12.  Remember that the cells are can never exposed to the air unless they are in the hood.  
Be sure to cover the 96 well plate, screw the cap on the flasks, etc.  All other pipettes and 
cell scrapers must all be opened in the hood.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix C: Operating instructions for the LVEM 
(Schrand & Hussain, 2010). 
 
 
PURPOSE/PRINCIPLE:  This standard operating procedure describes methods for 
using the Low Voltage Electron Microscope (LVEM).   
 
KEY WORDS:  Nanoparticle agglomeration, Cell uptake 
 
1.     SAFETY AND OPERATING PRECAUTIONS: 
 
 1.1 Wear appropriate gloves when handling samples/sample holder. 
 
 1.2 Properly dispose of unused/spent toxic materials (nanoparticles). 
 
2.    EQUIPMENT/MATERIALS: 
 
 2.1 Cu TEM grids, preferably carbon-coated or uncoated 
 
2.2 Nanoparticles in solution (typically water or ethanol) 
 
 
4. PROCEDURE: 
 
 4. 1  Prepare samples on TEM grids by drop-casting solution with 
micropipetter onto Whatman’s filter paper to remove excess solution (typically 
NP solution concentrations should be ~50 µg/ml for ease in finding NPs).  Store 
in grid box until ready to image. 
 
 4.2    IP switch remains ON, do not turn this off.  
 
4.3 Turn on the microscope (MIC) switch. 
 
4.4       Turn on the camera (top of camera has its own switch) 
 
4.5       Turn on turbo pumps (PS). 
 
4.5       Open software on computer by double-clicking icon. 
 
4.6       Log in with username and password:  guest, guest on computer and sign in 
log book with Name, Date, Time, Initial ip1 and ip2 values.   
 
4.7  Wait for vacuum pump LED to change from red/orange to GREEN 
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4.8 If sample holder left in LVEM, pull straight out---this is the preferred 
storage location for sample holder.  You should see little nub on holder 
before pulling out. (if not please find Amanda for further instruction) 
 
4.9 Insert TEM grid into holder with provided sample holder carrier by gently 
lifting Cu flap and replacing it with fine tweezers.   
 
4.10 Re-insert sample holder into LVEM by pushing straight back.  Turn 
airlock to GREEN tape (open).  Wait for LED light to turn GREEN, then 
continue to insert sample by turning holder 45º clockwise and slowly 
pushing in (requires some force).  Watch ip1 values (sample chamber ip 
current).  These must be in black before HV turned on (Step 4.13) 
 
4.11 Fasten silver knob until tight (do not over tighten), then press in black 
knob at the end of the sample holder. 
 
4.12 Turn on electron gun (HV) on the black console and notice that small 
RED light comes on at the top of the sample chamber.  WAIT ~ 15 
minutes for gun emission to stabilize to 5.4 kV (Preset).  With objective 
lenses out of the way of the YAG screen, you should be able to see a dot 
indicative of the electron beam.  If not, adjust HV (~5.15kV) and move 
sample with joystick on black console until a dot is present in the center of 
the YAG screen.  
 
4.13 Turn objective lens to 4x objective, then click VIEWS, CAMERA, 
START/STOP from software menu to view beam on the computer screen.  
Spread beam out by adjusting HV, gain (ie. 500).  *Make sure camera 
was turned on at the top of the LVEM and that the pull out knob on 
the side of the camera is all the way out. 
 
4.14 For an overview of the sample, select MODE, SCAN MODE.  For TEM, 
change to MODE, TEM.  To change magnification, use black knob on 
console.  To adjust focus, use HV and Z height adjustment on sample 
stage as well as the YAG dial.  *It may be easier to start focusing on the 
edge of the grid. 
 
4.15 TO CHANGE/REMOVE SAMPLE:     Turn off HV, unscrew silver knob, 
pull sample holder straight out, CAREFUL HERE:  turn sample holder 
30º (you should see small silver knub in sample exchange area), close 
off valve (you should see orange tape), LED should be GREEN, pull 
holder straight out, remove sample from sample holder and place in grid 
box for storage) 
 
4.16 TO REINSERT NEW SAMPLE:  Ensure that LED light is GREEN, then 
start at step 4.10 above.  *Make sure that LED light is GREEN, no HV 
 
  
is on (there is NO small red light on above sample chamber) before 
proceeding with sample insertion. 
 
4.17 SHUT DOWN:  Remove sample from holder as described in step 4.15 and 
place grid for storage in grid box.  Push sample holder (without any 
sample in it) into sample chamber for storage, *HV must be turned OFF, 
you should see orange tape indicating that vacuum valve is CLOSED, 
turn off MIC and PS, turn off camera at top of microscope, close 
software, touch computer screen for screen-saver mode.  
 
RECORDING IMAGES/SAVING FILES: 
   
5.1       In the VIEWS, CAMERA, START/STOP, select CAPTURE IMAGE to 
take a final picture, then select where you want to save file in your user 
folder. Keep the magnification as part of the image if you want to calibrate 
for size measurements later on (See attachment on QCapture Pro Software 
to make measurements on image). 
 
QUALITY CONTROL: 
7.1 Check with Amanda on beam alignments when sample is removed for 
correct position/stigmatism. 
 
LIMITATIONS OF PROCEDURE: 
8.1  Very small nanoparticles, thick sections and coated grids may pose 
imaging problems in LVEM.  No samples can be wet. 
             
9.    PROCEDURE NOTES:   
 
10.   REFERENCES:   
 
11. ATTACHMENTS:  
Attachment 1:  About the LVEM System  
Attachment 2:  QCapture Pro Software for Measuring Images 
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ATTACHMENT 1:  About the LVEM System 
 
 
ATTACHMENT 2:  QCapture Pro 6.0 Software for Measuring Images 
1. Turn on computer. 
2. Switch camera on (black switch on top of camera). 
2. Open the QCapture Pro 6.0 software. 
4. File, open, desktop, user files, select folder/file and open 
5. To measure, select measure on menu bar, calibration, calibration wizard, calibrate 
active image, LVEM_TEM mode_mag, nanometers, next, draw reference line, “1000” 
or other units to match current micron bar on image 
6.  Check your calibration with Calibration, select spatial, marker, move, right click to 
burn to image 
7.  To make measurements, select Measure, measure distances, measure the area on 
image, then under the Measure menu select snap measurements to burn them to image, 
then file save as (rename with _measured or other label to distinguish from original 
file). 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix D: Checklist for the Transmission Electron Microscope – CM 200 Lab 6 
Provided by Dr. Robert Wheeler, modified by Capt S. V. Brownheim 
 
The TEM at Lab 6 at the Materials Lab is a 200 kV TEM 
 
1. Make sure panel lights are on – two LEDs should be on: UHV and HVAC 
2. Check the system vacuum, make sure IGP < 20, P3 < 70 
3. High Tension (HT) = 200 kV?   
4. LN2 – Liquid nitrogen should be filled in the canister and coils remain cooled 
5. Load TEM specimen with correct tools onto appropriate sample holder, check for 
dust particles on O-ring and clean as necessary 
6. Load TEM sample holder along with specimen in the following way: 
a. Check vacuum again 
b. Start inserting sample with the small pin pointed in the 3 o-clock position 
while inserting the rod as straight as possible 
c. A “catch” should be felt and the vacuum pump should start pumping, the 
red light should turn on near the sample holder 
d. Spin from the 3 o-clock position to the 5 o-clock position and gently put 
the sample holder into the recess 
e. Select the correct holder on the screen, connect the plug, and press “ready” 
f. When the vacuum stops pumping the red light should go out 
g. Starting “opening” the sample, waiting for IGP to jump and then stabilize  
h. Wait for equilibration, then completely open and feed the sample holder 
the rest of the way in until secured 
i. Specimen is now loaded  
7. C2 Aperture  - using the top aperture to adjust and center the maximum 
illumination from the electron beam possible 
8. Eucentric Height (Objective Lens should equal 5480) – adjust by using “step” size 
knobs 
9. Gun Tilt – make the illumination as bright as possible 
10. Gun Shift 
11. Pivot Points 
12. Rotation Alignment – press the “ROT CENTER” button to optimize image and 
make the image move the least amount possible   
 
*The image on the next page shows the control panels on the TEM  
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Appendix E: Cell Sample Preparation for the Scanning Electron Microscope 
(Schrand, 2006). 
 
 
1.  Allow sufficient time to start and complete protocol.  Typically, the fixation and 
dehydration take half of a day and then the cells are left overnight.  The next day, drying, 
mounting, coating, and imaging would require an additional 3 or more hours. 
 
2.  Grow cells on Aclar polymer discs or other surface in multi-well dishes according to 
standard cell culture techniques. 
 
3.  Remove growth medium and wash 2X each for 10 minutes with PBS. 
 
4.  Add glutaraldehyde/Na cacodylate solution (2.5% glut/form in 0.1M Na caco pH 7.4) 
at 4 °C for 1 hour to fix. 
 
5.  Remove fixative and wash 3X each for 15 minutes with 0.1 M Na caco buffer, pH 7.4 
(dilute 0.2M in half with double distilled deionized water). 
 
6.  Remove buffer and start dehydration series (50, 70, 90, 100, 100, 100, 100%) in 
ethanol for 15 minutes each, then leave in fresh 100% ethanol overnight in a closed dish 
to prevent evaporation. 
 
7.  Transfer cells in multiwell plates in 100% ethanol to the NEST at UD. 
 
8.  Critical Point dry and mount to SEM stub with double-sided carbon tape. 
 
9.  Coat with gold in sputter coater. 
 
10.  Image in High Resolution SEM (make sure that you have been properly trained or a 
staff person is available to assist you on the instrument.  Once you are trained, the time 
can be scheduled online at www.nestlaboratory.com before showing up for your session). 
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Appendix F: Operating Instructions for Malvern’s Zetasizer for Dynamic Light 
Scattering (DLS) 
 
 
1. Log on to DLS computer. 
2. Open Zetasizer software and click on “manual measurement”, ensuring proper 
settings are set and select the correct sample holder.  For zeta potential 
measurements the clear zeta cuvette must be selected.  Select either “size” or 
“zeta potential” to run with. 
3. Vortex sample.  
4. Close cuvette with the appropriate tops and insert into cuvette holder. 
5. Click the measure button.   
6. Measurement records are saved automatically in the main record area under the 
file name.  Data can be exported to Microsoft Excel or Microsoft Word.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix G: Hyperspectral Imaging 
 
                                                     
 
 
Olympus IX71 Inverted Fluorescent Microscope with CytoViva 150 attachment and 12 bit 
QICAM from IMAGINE (Lab 160) 
 
 
 
        
HSI system set up, picture from the manufacturer (Cytoviva, 2011). 
http://www.cytoviva.com/product_hyperspectral_imaging.htm  
 
1. Samples of the N2A cells or particles are dropped onto glass slides.  Cells are 
covered with a glass cover-slip and sealed around the edges with nail polish.  Care 
is taken to ensure there’s not too much cell solution on the glass slide.  Particles at 
the desired concentration are dropped onto the glass slides and allowed to dry 
under the hood.  Glass cover-slips are added and the edges are sealed with nail 
polish. 
 
2. Once the sample slides are prepared the HSI system was used to capture the 
images of the samples and appropriate spectra are captured. 
150w Halogen 
Light Source 
Dual Mode Fluorescence Module Cytoviva Equipped 
Optical Microscope 
Imaging Camera 
VNIR Hyperspectral Imager 
Optical Image 
Hyperspectral Data 
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